Press release
Ovarian Cancer Industry to Grow at a CAGR of 11.40% during 2022-2027 -IMARC Group
What are the growth prospects of the Ovarian Cancer Industry?
The global ovarian cancer market size reached US$ 1.68 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.34 Billion by 2027, exhibiting a growth rate (CAGR) of 11.40% during 2022-2027.
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request For Sample Report https://www.imarcgroup.com/ovarian-cancer-market/requestsample
What is a Ovarian Cancer Market ?
Ovarian cancer represents a malignant tumor wherein irregular cells in the begin to develop and multiply uncontrollably from the outer tissue lining or fallopian tubes, owing to mutagenic changes in the deoxyribonucleic acid (DNA). It can be treated through various diagnoses and drugs, such as antineoplastic, antirheumatics, mitotic, PARP, and VEGF/VEGFR inhibitors.
In addition, ovarian cancer treatment involves chemotherapy, surgery, hormone, radiation, and targeted therapies that aid in killing the cancer cells to provide relief from signs and systems. These therapeutics are conducted by medical practitioners across hospitals and specialty centers after determining several factors, such as the spread of the tumor, the general health of an individual, and the size and type of ovarian cancer.
What are the major market drivers in the Ovarian Cancer Market ?
The escalating prevalence of epithelial, stromal, and germ cell cancer, especially among the female geriatric population, on account of the genetic mutation of BRCA2 or breast cancer gene 1 (BRCA1), is primarily driving the ovarian cancer market. Besides this, the elevating requirement for effective therapeutic drugs, including bevacizumab (Avastin) and pazopanib (Votrient), is further augmenting the market growth.
Moreover, the launch of several policies by the government bodies to sensitize consumers toward the treatments, symptoms, and benefits of early ovarian cancer diagnosis is also catalyzing the global market. Apart from this, the growing popularity of combination therapies in the healthcare sector to increase medicine efficacy and prevent drug resistance is acting as another significant growth-inducing factor.
Additionally, the ongoing patent expiration of branded medications has prompted pharmaceutical companies to launch novel recombinant drugs, which is also stimulating the market growth. Furthermore, the strategic collaborations among the leading players and the extensive research and development (R&D) activities to produce efficient therapeutic interventions are anticipated to propel the ovarian cancer market over the forecasted period.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/ovarian-cancer-market
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
o Epithelial Ovarian Cancer
o Germ Cell Ovarian Cancer
o Stromal Cell Ovarian Cancer
Breakup by Treatment Type:
o Immunotherapy
o Chemotherapy
o Targeted Therapy
o Surgery
o Others
Breakup by End User:
o Hospitals
o Homecare
o Speciality Centre
o Others
By Geography:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom,
Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia,
Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are
AbbVie Inc.
Amneal Pharmaceuticals Inc.
AstraZeneca plc, Eli Lilly and Company
F. Hoffmann-La Roche AG, GSK plc
Hikma Pharmaceuticals PLC
Lupin Limited, Pfizer Inc.
and Teva Pharmaceutical Industries Ltd.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Browse Other Industry Research Report-
Intravenous (IV) Ibuprofen Market Size 2022-2027-https://www.imarcgroup.com/intravenous-ibuprofen-market
Motor Insurance Market Report 2022-2027-https://www.imarcgroup.com/motor-insurance-market
Solar Farm Market Forecast 2022-2027-https://www.imarcgroup.com/solar-farm-market
Prestressed Concrete (PC) Wire and Strand Market Size 2022-2027- https://www.imarcgroup.com/prestressed-concrete-wire-strand-market
HVDC Transmission Systems Market size 2022-2027-https://www.imarcgroup.com/motor-insurance-market
Endoscopic Retrograde Cholangiopancreatography Market 2022-2027-https://www.imarcgroup.com/endoscopic-retrograde-cholangiopancreatography-market
FMCG Logistics Market Forecast 2022-2027-https://www.imarcgroup.com/fmcg-logistics-market
Nucleotides Market 2022-2027-https://www.imarcgroup.com/nucleotides-market
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Industry to Grow at a CAGR of 11.40% during 2022-2027 -IMARC Group here
News-ID: 2818930 • Views: …
More Releases from IMARC Group
India Fintech Market Size, Industry Share, Outlook, Top Companies Analysis & Rep …
According to IMARC Group's report titled "India Fintech Market Size, Share, Trends and Forecast by Deployment Mode, Technology, Application, End User, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India fintech market size reached USD 121.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 550.9 Billion by 2033, exhibiting a growth rate…
India Medical Equipment Market Size, Industry Share, Top Companies Analysis & Re …
According to IMARC Group's report titled "India Medical Equipment Market Size, Share, Trends and Forecast by Product Type, Application, End User, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India medical equipment market size reached USD 28.63 billion in 2024. Looking forward, the market is expected to reach USD 60.38 billion by 2033, exhibiting a growth rate…
India Public Cloud Market Size, Industry Share, Top Companies Analysis & Report …
According to IMARC Group's report titled "India Public Cloud Market Size, Share, Trends and Forecast by Service, Enterprise Size, End Use, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India public cloud market size was valued at USD 27.38 Billion in 2024. Looking forward, the market is estimated to reach USD 191.66 Billion by 2033, exhibiting a…
India Cloud AI Market Trends, Size, Industry Share, Top Companies Analysis & Rep …
According to IMARC Group's report titled " India Cloud AI Market Size, Share, Trends and Forecast by Type, Technology, Vertical, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
Short Summary:
The India cloud AI market size reached USD 2.73 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 100.86 Billion by 2033, exhibiting a growth rate…
More Releases for Ovarian
Ovarian Cancer Diagnostics Market Size: 2033 Statistics
The Ovarian Cancer Diagnostics market is expected to grow from an estimated USD 4814.5 million in 2024 to USD 7795.1 million in 2033, at a CAGR of 5.50%.
The ovarian cancer diagnostics market plays a critical role in the early detection and management of ovarian cancer, one of the most common and lethal gynecological cancers worldwide. Ovarian cancer is often diagnosed at an advanced stage due to the lack of noticeable…
Ovarian Cancer Market Size, Future Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ovarian Cancer Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
